Enzo Biochem | 8-K: Current report
Enzo Biochem | 8-K: Current report
Enzo Biochem | 8-K: Current report
Enzo Biochem | 4: Statement of changes in beneficial ownership of securities-Officer Eckert Patricia
Enzo Biochem | 4: Statement of changes in beneficial ownership of securities-Officer Cannon Kara
Enzo Biochem | 11-K: Annual report of employee stock purchase, savings and similar plans (and amendment thereto)
Enzo Biochem | 10-Q: Q3 2024 Earnings Report
Enzo Biochem | 4: Statement of changes in beneficial ownership of securities-Officer Cannon Kara
Enzo Biochem | 8-K: Current report
Enzo Biochem | 8-K: Enzo Biochem Reports Second Quarter Fiscal 2024 Results and Provides Business Update
Enzo Biochem | 10-Q: Q2 2024 Earnings Report
Enzo Biochem | 4: Statement of changes in beneficial ownership of securities-Officer Cannon Kara
Enzo Biochem | 8-K: Current report
Enzo Biochem | 4: Statement of changes in beneficial ownership of securities-Officer Eckert Patricia
Enzo Biochem | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-1 Main Capital Management, LLC(4.95%),Yaron Naymark(4.95%), etc.
Enzo Biochem | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Renaissance Technologies LLC 26-0385758(4.91 %),RENAISSANCE TECHNOLOGIES HOLDINGS CORPORATION 13-3127734(4.91 %)
Enzo Biochem | 4: Statement of changes in beneficial ownership of securities-Director PULLY STEVEN J
Enzo Biochem | 4: Statement of changes in beneficial ownership of securities-Director TAGLIAFERRI MARY
Enzo Biochem | 4: Statement of changes in beneficial ownership of securities-Director Radoff Bradley Louis
Enzo Biochem | 8-K: Current report
No Data